U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H32O5
Molecular Weight 352.4651
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of 15-OXOPROSTAGLANDIN E1

SMILES

CCCCCC(=O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O

InChI

InChIKey=VXPBDCBTMSKCKZ-XQHNHVHJSA-N
InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,16-17,19,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t16-,17-,19-/m1/s1

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Human prostaglandin reductase 1 (PGR1): Substrate specificity, inhibitor analysis and site-directed mutagenesis.
2015 Jun 5
Name Type Language
15-OXOPROSTAGLANDIN E1
Common Name English
U-22409
Code English
15-OXO-PGE1
Common Name English
7-((1R,2R,3R)-3-HYDROXY-2-((1E)-3-OXOOCT-1-ENYL)-5-OXOCYCLOPENTYL)HEPTANOIC ACID
Systematic Name English
15-KETOPROSTAGLANDIN E1
Common Name English
15-KETO-PROSTAGLANDIN E1
Common Name English
ALPROSTADIL IMPURITY C [EP IMPURITY]
Common Name English
PROST-13-EN-1-OIC ACID, 11-HYDROXY-9,15-DIOXO-, (11.ALPHA.,13E)-
Systematic Name English
15-KETO-PGE1
Common Name English
Code System Code Type Description
PUBCHEM
5280710
Created by admin on Sat Dec 16 07:55:36 GMT 2023 , Edited by admin on Sat Dec 16 07:55:36 GMT 2023
PRIMARY
CAS
22973-19-9
Created by admin on Sat Dec 16 07:55:36 GMT 2023 , Edited by admin on Sat Dec 16 07:55:36 GMT 2023
PRIMARY
EPA CompTox
DTXSID601216545
Created by admin on Sat Dec 16 07:55:36 GMT 2023 , Edited by admin on Sat Dec 16 07:55:36 GMT 2023
PRIMARY
FDA UNII
63FR527UJ6
Created by admin on Sat Dec 16 07:55:36 GMT 2023 , Edited by admin on Sat Dec 16 07:55:36 GMT 2023
PRIMARY
CHEBI
57401
Created by admin on Sat Dec 16 07:55:36 GMT 2023 , Edited by admin on Sat Dec 16 07:55:36 GMT 2023
PRIMARY